Prior to the revision of the TNM.

Prior to the revision of the TNM, was the most important conventional prognostic factor for patient survival tumor stage at diagnosis, including tumor size, pleural invasion, involvement of regional lymph nodes and metastases to distant organs. However, the revised guidelines were age, gender , and performance status , next to the stage, all to be the prognostic factors for survival. Correlated within the current study, expression of PS and new p – stage, further years with a progression-free survival and cancer-specific survival correlated, regardless of tumor histology. Markers that are overexpressed in tumor progression is of particular interest because they are used not only the outcome of patients the outcome of patients, but also serve as potential targets in cancer therapy, such as epidermal growth factor receptor gene are, lead investigator Dr.

The two other biomarkers are used, induction of chromosomal aberrations in non-irradiated cultures at different concentrations, and sister chromatid exchange , a genetic biomarker of exposure to chemicals. ‘With this study, we already know that vitro vitro experimental level, the concentration of propolis to make it radiation radiation protection agent, without being cyto / genotoxic to normal cells, this is the first step, a base point for future clinical. The ultimate objective is to develop capsules with the appropriate dose of propolis, but many more hours of research are required before we ‘do be able to, adds adds Alegria Montoro.The Future of Regenerative Medicine technological advances in technological advances in cell of preparation or processing operation and the investment of outcome-based clinical studies Celling Electronics ‘ experience in the delivery and clinical evaluation stem cell therapies, with thermogenesis combines expertise to cell fractionation., isolation and characterization, for a team continue the adult at the development of point-of -care stem cells therapy will lead.